Acute, muscle-type specific insulin resistance following injury

Molecular Medicine

Volumn 14, Issue 11-12, 2008, Pages 715-723

  Thompson, LaWanda H ^a   Kim, Hyeong T ^b   Ma, Yuchen ^a   Kokorina, Natalia A ^a   Messina, Joseph L ^a,c  

^a University of Alabama at Birmingham   (United States)

^b CHA University   (South Korea)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN KINASE B; TYROSINE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; DIAPHRAGM; DISEASE SEVERITY; EXTENSOR DIGITORUM LONGUS MUSCLE; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; SURGICAL INJURY; TRICEPS BRACHII MUSCLE;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; DIAPHRAGM; HEMORRHAGE; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; MYOCARDIUM; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 55749096430     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00081.Thompson     Document Type: Article

References (47)

1. Avruch J. (1998) Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 182:31-48.
2. White MF, Kahn CR. (1994) The insulin signaling system. J. Biol. Chem. 269:1-4.
3. Zick Y. (2001) Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 11:437-41.
4. White MF. (2002) IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283:E413-22.
5. Kahn CR. (1978) Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27:1893-902.
6. Ma Y, Wang P, Kuebler JF, Chaudry IH, Messina JL. (2003) Hemorrhage induces the rapid development of hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G107-15.
7. Ma Y, et al. (2004) Mechanisms of hemorrhageinduced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 145:5168-76.
8. Xu J, et al. (2008) Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor (TNF)-alpha. Endocrinology 149:2369-82.
9. Carter EA. (1998) Insulin resistance in burns and trauma. Nutr. Rev. 56:S170-6.
10. Allsop JR, Wolfe RR, Burke JF. (1978) Glucose kinetics and responsiveness to insulin in the rat injured by burn. Surg. Gynecol. Obstet. 147:565-73.
11. Turinsky J, Saba TM, Scovill WA, Chesnut T. (1977) Dynamics of insulin secretion and resistance after burns. J. Trauma 17:344-50.
12. Clemens MG, Chaudry IH, Daigneau N, Baue AE. (1984) Insulin resistance and depressed gluconeogenic capability during early hyper-glycemic sepsis. J. Trauma-Injury Infect. Crit. Care 24:701-8.
13. Lang CH, Dobrescu C. (1989) In vivo insulin resistance during nonlethal hypermetabolic sepsis. Circulatory Shock 28:165-78.
14. Chaudry IH, Sayeed MM, Baue AE. (1974) Insulin resistance in experimental shock. Arch. Surg. 109:412-5.
15. Strommer L, et al. (2001) Effect of carbohydrate feeding on insulin action in skeletal muscle after surgical trauma in the rat. Nutrition 17:332-6.
16. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. (2000) Insulin resistance and substrate utilization in human endotoxemia. J. Clin. Endocrinol. Metab. 85:3770-8.
17. Van den Berghe G, et al. (2001) Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359-67.
18. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. Endocrinol. Metab. 88:1082-8.
19. DeFronzo RA, et al. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-7.
20. Bamman MM, et al. (2004) Myogenic protein expression before and after resistance loading in 26- and 64-yr-old men and women. J. Appl. Physiol. 97:1329-37.
21. Keeton AB, et al. (2003) Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology 144:5402-10.
22. Keeton AB, Amsler MO, Venable DY, Messina JL. (2002) Insulin Signal Transduction Pathways and Insulin-induced Gene Expression. J. Biol. Chem. 277:48565-73.
23. Hill MM, Feng J, Hemmings BA. (2002) Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12:1251-5.
24. Cline GW, et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes [see comments]. N. Engl. J. Med. 341:240-6.
25. Lang CH, Dobrescu C, Meszaros K. (1990) Insulinmediated glucose uptake by individual tissues during sepsis. Metabolism 39:1096-107.
26. Sugita H, et al. (2005) Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288:E585-91.
27. Wilmore DW, Mason AD Jr, Pruitt BA Jr. (1976) Insulin response to glucose in hypermetabolic burn patients. Ann. Surg. 183:314-20.
28. Carey LC, Lowery BD, Cloutier CT. (1970) Blood sugar and insulin response of humans in shock. Ann. Surg. 172:342-50.
29. Krook A. (1998) Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47:1281-6.
30. Nunes AL, Carvalheira JB, Carvalho CR, Brenelli SL, Saad MJ. (2001) Tissue-specific regulation of early steps in insulin action in septic rats. Life Sci. 69:2103-12.
31. Gore DC, et al. (2002) Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit. Care Med. 30:2438-42.
32. Ikezu T, Okamoto T, Yonezawa K, Tompkins RG, Martyn JA. (1997) Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J. Biol. Chem. 272:25289-95.
33. Vivanco I, Sawyers CL. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489-501.
34. James DE, Jenkins AB, Kraegen EW. (1985) Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am. J. Physiol. 248:E567-74.
35. Krook A, et al. (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284-92.
36. Klein HH, Vestergaard H, Kotzke G, Pedersen O. (1995) Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 44:1310-7.
37. Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH. (2002) Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45:813-22.
38. Caro JF, et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 79:1330-7.
39. Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB. (2003) Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes 52:1935-42.
40. Arner P, Pollare T, Lithell H, Livingston JN. (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:437-40.
41. Maegawa H, Shigeta Y, Egawa K, Kobayashi M. (1991) Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40:815-9.
42. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky, JM. (1994) Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J. Clin. Endocrinol. Metab. 78:471-7.
43. Bjornholm M, Kawano Y, Lehtihet M, Zierath JR. (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524-7.
44. Cusi K, et al. (2000) Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105:311-20.
45. Esposito DL, Li Y, Cama A, Quon MJ. (2001) Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142:2833-40.
46. Ferrando AA, et al. (1999) A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann. Surg. 229:11-8.
47. Mesotten D, Van den Berghe G. (2003) Clinical potential of insulin therapy in critically ill patients. Drugs 63:625-36.